Cerity Partners
RYTM icon

Cerity Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Cerity Partners’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348K Sell
3,137
-78
-2% -$7.05K ﹤0.01% 2689
2026
Q1 		$280K Sell
3,215
-449
-12% -$43.7K ﹤0.01% 2661
2025
Q4 		$392K Buy
3,664
+700
+24% +$74.3K ﹤0.01% 2250
2025
Q3 		$299K Buy
+2,964
New +$275K ﹤0.01% 2284

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cerity Partners's RYTM Position: Q2 2026 in Review

Cerity Partners reduced its Rhythm Pharmaceuticals (RYTM) stake by 2.4% in Q2 2026, selling an estimated $7.05K and leaving 3,137 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #2689.

Cerity Partners first reported a position in RYTM in Q3 2025 and has held it in 4 quarters since. The position peaked at $392K in Q4 2025. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Cerity Partners held 3,137 shares of Rhythm Pharmaceuticals worth $348K as of Q2 2026.
  • Cerity Partners sold 78 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $7.05K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2689 holding.
  • Cerity Partners first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Cerity Partners's Rhythm Pharmaceuticals position peaked at $392K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.